IFNG and neoplasm: A Δcps vaccine was found to be able to reverse the immunosuppression of tumors, increase the production of type 1 helper cell (Th1) cytokines IL-12 and IFN-γ and activate tumor-related CD8+ T cells to recognize and kill tumor cells [32–37].